0001415889-21-000527.txt : 20210203
0001415889-21-000527.hdr.sgml : 20210203
20210203191054
ACCESSION NUMBER: 0001415889-21-000527
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210201
FILED AS OF DATE: 20210203
DATE AS OF CHANGE: 20210203
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chapman Steven Leonard
CENTRAL INDEX KEY: 0001711968
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37478
FILM NUMBER: 21588046
MAIL ADDRESS:
STREET 1: 201 INDUSTRIAL ROAD, SUITE 410
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Natera, Inc.
CENTRAL INDEX KEY: 0001604821
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 010894487
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 201 INDUSTRIAL ROAD
STREET 2: SUITE 410
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
BUSINESS PHONE: 650-249-9090
MAIL ADDRESS:
STREET 1: 201 INDUSTRIAL ROAD
STREET 2: SUITE 410
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
4
1
form4-02032021_040235.xml
X0306
4
2021-02-01
0001604821
Natera, Inc.
NTRA
0001711968
Chapman Steven Leonard
C/O NATERA, INC.
201 INDUSTRIAL RD SUITE 410
SAN CARLOS
CA
94070
true
true
false
false
CHIEF EXECUTIVE OFFICER
Common Stock
2021-02-01
4
M
0
525
10.41
A
37689
D
Common Stock
2021-02-01
4
M
0
198
10.73
A
37887
D
Common Stock
2021-02-01
4
M
0
443
9.29
A
38330
D
Common Stock
2021-02-01
4
M
0
281
13.01
A
38611
D
Common Stock
2021-02-01
4
M
0
1688
13.01
A
40299
D
Common Stock
2021-02-01
4
M
0
490
20.27
A
40789
D
Common Stock
2021-02-01
4
M
0
215
25.46
A
41004
D
Common Stock
2021-02-01
4
S
0
1926
107.6985
D
39078
D
Common Stock
2021-02-01
4
S
0
1914
108.5433
D
37164
D
Stock Option (right to buy)
10.41
2021-02-01
4
M
0
525
0
D
2027-06-08
Common Stock
525
9194
D
Stock Option (right to buy)
10.73
2021-02-01
4
M
0
198
0
D
2027-07-13
Common Stock
198
3865
D
Stock Option (right to buy)
9.29
2021-02-01
4
M
0
443
0
D
2028-03-08
Common Stock
443
46718
D
Stock Option (right to buy)
13.01
2021-02-01
4
M
0
281
0
D
2029-01-10
Common Stock
281
52531
D
Stock Option (right to buy)
13.01
2021-02-01
4
M
0
1688
0
D
2029-01-10
Common Stock
1688
77687
D
Stock Option (right to buy)
20.27
2021-02-01
4
M
0
490
0
D
2029-04-11
Common Stock
490
58572
D
Stock Option (right to buy)
25.46
2021-02-01
4
M
0
215
0
D
2030-03-26
Common Stock
215
39431
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2020.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.40 to $108.03 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.05 to $108.82 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The option shares vest over four years. 25% of the option shares vested and became exercisable on March 21, 2018 and the remaining shares vest in 36 equal monthly installments thereafter.
The option shares vest over four years. 25% of the option shares vested and became exercisable on March 12, 2018 and the remaining shares vest in 36 equal monthly installments thereafter.
The option shares vest over four years. 25% of the option shares vested and became exercisable on March 9, 2019 and the remaining shares vest in 36 equal monthly installments thereafter.
The option shares vest over four years. 25% of the option shares vested and became exercisable on January 2, 2020 and the remaining shares vest in 36 equal monthly installments thereafter.
This option becomes exercisable, if at all, upon the Reporting Person achieving certain milestones relating to a combination of the passage of time and the Reporting Person achieving certain milestones relating to the Issuer's stock price, based on the average closing price per share of the Issuer's common stock for a calendar month, calculated as of the last day of such calendar month. The first milestone is the Issuer's stock price equaling or exceeding the quotient of (i) $2,000,000,000 and (ii) the Issuer's outstanding shares as most recently reported on the Issuer's Form 10-Q or Form 10-K (the "Capitalization"). The second milestone is the Issuer's stock price equaling or exceeding the quotient of (i) $3,000,000,000 and (ii) the Capitalization (the "Performance Vesting Conditions"). As of December 18, 2020, the Company's Board of Directors determined the performance criteria had been met with respect to 18,750 additional shares.
The option shares vest over four years. 25% of the option shares vested and became exercisable on March 22, 2020 and the remaining shares vest in 36 equal monthly installments thereafter.
The option vests upon the Reporting Person achieving certain milestones relating to a combination of the passage of time and the Reporting Person achieving certain milestones relating to the Issuer's stock price. As of October 1, 2020, the Company's Board of Directors determined the performance criteria had been met with respect to 37,500 shares.
/s/ Tami Chen, Attorney-in-Fact
2021-02-03